Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
for
ALS
Location: Boston MA, Montreal, Philadelphia PA,
Sponsor: Amylyx Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06665165
Phase1, Recruiting
Embo Registry; National Registry for Artery Embolization
Location: Stony Brook NY, Philadelphia PA, Washington D.C. DC,
Sponsor: CoMind Technologies Limited
Sex: All
Age: 18+
Code: NCT06368648
Recruiting
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
for
Alopecia
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 7+
Code: NCT04764357
Recruiting
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
for
Glaucoma, Open-Angle, Ocular Hypertension
Location: New Smyrna Beach FL, Morrow GA, Roswell GA,
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT05401357
Phase3, Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Long Island City NY, Manhattan NY, Fairfax VA,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase1, Phase2, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy